Published in J Exp Med on April 20, 1998
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 3.51
B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med (1999) 1.55
Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol (2005) 1.55
NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection. J Leukoc Biol (2015) 1.46
Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med (1999) 0.98
Human B-1 cells take the stage. Ann N Y Acad Sci (2013) 0.97
X-chromosome-linked immune-deficient mice have B-1b cells. Immunology (2003) 0.88
Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc Natl Acad Sci U S A (2012) 0.87
Btk regulates multiple stages in the development and survival of B-1 cells. Mol Immunol (2007) 0.85
Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82
Natural IgM anti-leucocyte autoantibodies (IgM-ALA) regulate inflammation induced by innate and adaptive immune mechanisms. J Clin Immunol (2014) 0.79
Functional dissection of the cytoplasmic subregions of the interleukin-5 receptor alpha chain in growth and immunoglobulin G1 switch recombination of B cells. Immunology (2001) 0.78
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front Immunol (2016) 0.77
Peripheral blood CD5-positive B lymphocytes (B-1a cells) after allogeneic stem cell transplantation for acute myeloid leukaemia in humans. Blood Transfus (2008) 0.77
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74
Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science (1993) 5.50
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Defective B cell development and function in Btk-deficient mice. Immunity (1995) 4.20
Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 4.16
Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (1995) 4.10
Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science (1993) 4.08
Origin of murine B cell lineages. Annu Rev Immunol (1993) 3.82
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
The Ly-1 B cell lineage. Immunol Rev (1986) 3.59
Immunodeficiency in protein kinase cbeta-deficient mice. Science (1996) 2.79
The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol (1982) 2.79
Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity (1995) 2.69
Rheumatoid factor secretion from human Leu-1+ B cells. Science (1987) 2.65
Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60
Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature (1995) 2.50
The CD5 B cell. Adv Immunol (1989) 2.49
Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol (1986) 2.30
Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29
Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science (1986) 2.24
Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes. Nature (1995) 2.22
B-cell subpopulations identified by two-colour fluorescence analysis. Nature (1982) 2.06
A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J Immunol (1989) 2.05
A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A (1991) 1.96
Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol (1991) 1.90
CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J Immunol (1996) 1.90
X-linked B-lymphocyte defect in CBA/N mice. III. Abnormal development of B-lymphocyte populations defined by their density of surface immunoglobulin. J Exp Med (1976) 1.84
All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. Int Immunol (1990) 1.82
Impaired expansion of mouse B cell progenitors lacking Btk. Immunity (1995) 1.79
The primary immunodeficiencies (1). N Engl J Med (1984) 1.74
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Rearrangement and selection of VH11 in the Ly-1 B cell lineage. J Exp Med (1990) 1.54
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med (1981) 1.40
Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med (1994) 1.40
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med (1978) 1.37
The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci U S A (1995) 1.35
Early B-cell development in the mouse: insights from mutations introduced by gene targeting. Immunol Rev (1994) 1.35
B-1 cells are made, not born. Immunol Today (1993) 1.32
Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA. J Clin Invest (1982) 1.30
An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis. Proc Natl Acad Sci U S A (1996) 1.29
The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur J Immunol (1990) 1.25
A new nomenclature for B cells. Immunol Today (1991) 1.13
Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras. J Exp Med (1984) 1.08
Surface markers, heavy chain sequences and B cell lineages. Int Rev Immunol (1992) 1.00
The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor. EMBO J (1996) 0.96
xid affects events leading to B cell cycle entry. J Immunol (1997) 0.90
Early arrest of B cell development in nude, X-linked immune-deficient mice. Eur J Immunol (1986) 0.90
Radiation-induced apoptosis is differentially regulated in primary B cells from normal mice and mice with the CBA/N X-linked immunodeficiency. J Immunol (1995) 0.90
B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid). J Immunol (1985) 0.88
Physiology of B cells in mice with X-linked immunodeficiency. I. Size, migratory properties, and turnover of the B cell pool. J Immunol (1985) 0.85
VH CDR3-dependent positive selection of murine VH12-expressing B cells in the neonate. Eur J Immunol (1993) 0.83
The majority of murine VH12-expressing B cells are excluded from the peripheral repertoire in adults. Eur J Immunol (1995) 0.78
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. J Immunol (1988) 1.72
Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol (1989) 1.52
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J Immunol (1983) 1.49
Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes. J Exp Med (1986) 1.43
High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. J Immunol (1990) 1.43
Dextran sulphate: an adjuvant for cell-mediated immune responses. Immunology (1977) 1.33
B-1 cells are made, not born. Immunol Today (1993) 1.32
Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice. Immunogenetics (1982) 1.23
Restricted immunoglobulin variable region gene usage by normal Ly-1 (CD5+) B cells that recognize phosphatidyl choline. J Exp Med (1989) 1.20
Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol (1996) 1.02
Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. J Pharmacol Exp Ther (1996) 1.01
Cross-reactive idiotypes and common antigen binding specificities expressed by a series of murine B-cell lymphomas: etiological implications. Proc Natl Acad Sci U S A (1985) 1.01
Anti-phencyclidine monoclonal Fab fragments markedly alter phencyclidine pharmacokinetics in rats. J Pharmacol Exp Ther (1994) 0.93
Induced differentiation of a B cell lymphoma with known antigen specificity. J Mol Cell Immunol (1984) 0.92
Role of cell surface immunoglobulin in B-lymphocyte activation. Proc Natl Acad Sci U S A (1984) 0.92
A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells. J Immunol (2001) 0.91
Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum. J Immunol (1980) 0.89
Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice. Immunology (2001) 0.87
Ig isotype switching in B lymphocytes. The effect of T cell-derived interleukins, cytokines, cholera toxin, and antigen on isotype switch frequency of a cloned B cell lymphoma. Int Immunol (1991) 0.86
Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep. Circulation (1999) 0.85
Selection at multiple checkpoints focuses V(H)12 B cell differentiation toward a single B-1 cell specificity. J Exp Med (1999) 0.82
Single breath CO2 analysis: description and validation of a method. Crit Care Med (1996) 0.82
Early commitment to neoplasia in murine B- and T-cell lymphomas arising late in life. J Natl Cancer Inst (1989) 0.80
Noninvasive determination of cardiac output using single breath CO2 analysis. Crit Care Med (1996) 0.80
Antigen-specific B cell tumors of mice. Crit Rev Immunol (1986) 0.78
Three classes of signalling molecules on B-cell membranes. J Cell Biochem (1985) 0.78
Ig isotype switching in B lymphocytes. A method for estimating isotype switch frequency in cloned B cell lymphomas. Int Immunol (1989) 0.78
A monoclonal antibody to the insect prothoracicotropic hormone. J Neurosci (1988) 0.78
CD3 expression, modulation and signalling in T-cell subpopulations from MRL/Mp-lpr/lpr mice. J Autoimmun (1991) 0.77
Precipitating factors in the female borderline syndrome--a dichotomy. Dis Nerv Syst (1977) 0.75
Noninvasive determination of cardiac output in a model of acute lung injury. Crit Care Med (1997) 0.75
The CH series of murine B cell lymphomas: identification of cross-reactive idiotypes and restricted antigen specificities. Curr Top Microbiol Immunol (1984) 0.75
Perturbation of early development of the immune system by normal adult lymphoid cells. J Immunol (1981) 0.75
Isotype switching in CD5 B cells. Ann N Y Acad Sci (1992) 0.75